OTRK.NASDAQOntrak, INC

8-K: Ontrak Health Reports Q1 2024 Financial Results, Revenue Up 6% Year-Over-Year

Sentiment:

Quarterly Report


Ontrak Health announced its Q1 2024 financial results, showing a 6% increase in revenue year-over-year and significant improvements in operating loss and adjusted EBITDA.

Capital raiseThe company issued and sold senior secured convertible promissory notes to Acuitas Capital, with a principal amount of $1.5 million each on April 5, 2024 and May 8, 2024.Acuitas Capital may purchase up to an additional $12.0 million in principal amount of Demand Notes.The company received $2.0 million in cash proceeds from the exercise of Public Offering Warrants.
Better than expectedThe company's operating loss and adjusted EBITDA improved significantly year-over-year, indicating better cost management and operational efficiency.

Summary

  • Ontrak Health reported a 6% increase in revenue for the first quarter of 2024, reaching $2.7 million compared to $2.5 million in the same period last year.
  • The company's operating loss improved by 41% year-over-year, decreasing from $(7.2) million to $(4.3) million.
  • Adjusted EBITDA also showed a significant improvement of 38%, moving from $(5.4) million to $(3.4) million year-over-year.
  • Net loss for the quarter was $(4.5) million, or $(0.11) per diluted share, compared to a net loss of $(8.4) million, or $(2.26) per diluted share, in Q1 2023.
  • Non-GAAP net loss was $(3.7) million, or $(0.10) per diluted share, compared to $(7.7) million, or $(2.12) per diluted share, in the prior year.
  • The company's WholeHealth+ program had 1,521 enrolled members at the end of Q1 2024, slightly down from 1,758 at the end of Q4 2023.
  • Ontrak's effective outreach pool increased significantly to 5,057 at the end of March 2024, compared to 2,161 at the end of December 2023.
  • The company secured a new customer agreement with a prominent regional Medicaid health plan, expected to increase the outreach pool by 10%.

Sentiment

Score: 7

Explanation: The document presents a mixed picture with positive revenue growth and improved profitability metrics, but ongoing losses and reliance on debt financing temper the overall sentiment. The new customer agreement and expansion of the outreach pool are positive indicators for future growth.

Positives

  • Revenue increased by 6% year-over-year, indicating growth in the business.
  • Significant improvements in operating loss and adjusted EBITDA demonstrate better cost management and operational efficiency.
  • The company secured a new customer agreement with a prominent regional Medicaid health plan, which is expected to increase the outreach pool by 10%.
  • The company's effective outreach pool has more than doubled since the end of 2023.
  • The company has demonstrated strong health outcomes with a high NPS score and significant improvements in patient health metrics.
  • The company has secured additional funding through the issuance of convertible promissory notes.

Negatives

  • The company continues to operate at a loss, with a net loss of $(4.5) million for the quarter.
  • The number of enrolled members in the WholeHealth+ program decreased slightly from the previous quarter.
  • The company's financial outlook for the next quarter projects a similar revenue range of $2.4 million to $2.8 million, indicating no significant growth acceleration.
  • The company is reliant on additional funding through the issuance of convertible promissory notes.

Risks

  • The company's ability to achieve profitability is still uncertain, as it continues to operate at a loss.
  • The company's financial performance is subject to risks related to customer concentration and contract terminations.
  • The company's ability to raise additional capital when needed is a risk factor.
  • The company faces risks related to enrolling new members and maintaining existing members in its programs.
  • The company is subject to substantial regulation in the healthcare industry.
  • The company is dependent on key personnel and faces risks related to recruiting and retaining talent.
  • The company is subject to ongoing legal proceedings and potential future investigations.
  • The company faces intense competition in the healthcare industry.

Future Outlook

The company estimates revenue in the range of $2.4 million to $2.8 million for the quarter ending June 30, 2024.

Management Comments

  • We are thrilled to announce our approval by the Florida Agency for Health Care Administration (AHCA) as a subcontractor for our new customer, Community Care Plan, a South Florida-based Health Plan to serve its adult Medicaid population, said Brandon LaVerne, the Company's Chief Executive Officer and Chief Operating Officer.
  • We are proud of our value proposition and ROI generation capabilities, including our NPS score of 77, improved GAD-7 and PHQ-9 scores of 41%-64% after nine months in our program, medical cost savings reduction of 43% and inpatient admissions reduction of 62%.
  • We continue to innovate our solutions and are excited to generate incremental value by delivering these evidenced-based health outcomes for the members we serve and cost reduction to our customers.

Industry Context

The announcement reflects the ongoing trend of healthcare companies focusing on technology-enabled solutions and value-based care models, particularly in the behavioral health sector. The company's focus on AI and data analytics aligns with industry trends towards personalized and efficient healthcare delivery.

Comparison to Industry Standards

  • While Ontrak's revenue growth of 6% is positive, it is important to compare this to other companies in the digital health and behavioral health space. Companies like Teladoc Health and Amwell, while larger, have seen varying growth rates, and it would be beneficial to benchmark Ontrak against similar-sized, specialized behavioral health providers.
  • The reported improvements in operating loss and adjusted EBITDA are encouraging, but it is crucial to assess these metrics against industry averages for companies in similar stages of development. Many early-stage digital health companies experience significant losses before achieving profitability, so Ontrak's progress should be viewed in this context.
  • The company's reported NPS score of 77 is a strong indicator of customer satisfaction, and the reported health outcome improvements are also positive. These metrics should be compared to industry benchmarks for similar programs to assess their relative effectiveness.
  • The company's reliance on convertible promissory notes for funding is not uncommon for companies in this stage, but it is important to monitor the terms of these notes and their potential impact on the company's capital structure. This is a common practice for companies that are not yet cash flow positive.

Legal Proceedings

  • The company is subject to ongoing legal proceedings brought by the U.S. Department of Justice and the Securities and Exchange Commission against the company's largest stockholder and former Chief Executive Officer and Chairman.

Stakeholder Impact

  • Shareholders may view the improved financial metrics and new customer agreement positively, but the ongoing losses and reliance on debt financing may cause concern.
  • Employees may be impacted by the company's cost-saving measures and restructuring efforts.
  • Customers (health plans) may benefit from the company's improved health outcomes and cost savings.
  • Members of the health plans may benefit from the company's programs and services.

Next Steps

  • The company expects to initiate outreach to new eligible members of the new health plan customer in the next 30 to 60 days.
  • The company will host a conference call/webcast to discuss the results.

Key Dates

DateDescription
February 29, 2024Ontrak announced the expansion of its WholeHealth+ program to a larger commercial population.
March 12, 2024Ontrak announced a continuing expansion of its strategic partnership to offer its program to eligible self-insured groups.
March 31, 2024End of the first quarter of 2024.
April 5, 2024The company issued and sold a senior secured convertible promissory note to Acuitas Capital.
May 8, 2024The company issued and sold a second senior secured convertible promissory note to Acuitas Capital.
May 14, 2024Ontrak announced its Q1 2024 financial results.

Keywords

Ontrak Health, Behavioral Healthcare, Financial Results, Q1 2024, Revenue, EBITDA, Medicaid, Healthcare, AI, Technology, Mental Health, Outreach, WholeHealth+, Promissory Notes

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.